May 5 (SeeNews) - Bulgarian drug maker Sopharma [BUL:SFA] said that its standalone net profit fell sharply to 4.6 million levs ($2.8 million/ 2.3 million euro) in the first three months of 2021 from 8.7 million levs in the same period of 2020, due to a decrease in revenue.